The observed neurologic manifestations were behavior or personality/mood changes, altered cognition, sleep disturbances, seizures, decreased level of consciousness, movement disorders.[4] However, the effects of mGluR5 antibodies are not clear. Here, GRM5 is linked to movement disorder.